跳至主要内容
临床试验/CTIS2022-501084-41-00
CTIS2022-501084-41-00招募中1 期

Xerostomia in patients with a life-limiting condition or frailty:a double-blind placebo-controlled randomized clinical trial - 2022-501084-41-00

niversity Hospital Maastricht0 个研究点目标入组 120 人开始时间: 2022年11月18日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 18 years or older, have a life-limiting condition or frailty, have the complaint dry mouth = 5 on an 11 point numerical rating scale (ranging from 0= no dry mouth to 10= worst dry mouth ever), fulfil the single SQ ‘Would I be surprised if my patient dies within the year? (no)

排除标准

  • a life expectancy of less than 4 weeks (the primary endpoint at 4 weeks), have/had radiotherapy to the salivary glands or suffer from Sjögrens disease (impact on dry mouth), cognitively impaired to such an extent that there is insufficient understanding to complete questionnaires

研究者

发起方
niversity Hospital Maastricht

相似试验